Asher A. Qazi

SEC Compliance, Disclosure and Governance Advice

• Bristol Myers Squibb
• Chewy
• Ferguson plc
• Ladder Capital
• Torrid

Debt Transactions

• AbbVie in its:
  
  • issuance of $30 billion of senior notes to finance its acquisition of Allergan
  • in its exchange offers and consent solicitations for ~$22 billion of Allergan debt in connection with AbbVie’s acquisition of Allergan
• Avaya in its:
  
  • issuance of $1.0 billion of senior first lien notes
  • issuance of $250 million of exchangeable notes
• Bristol Myers Squibb in its:
  • exchange offers and consent solicitations for ~$20 billion of Celgene debt
  • issuance of approximately ~$19 billion of senior notes
  • registered offering of approximately $13 billion of senior notes
  • registered offering of approximately $7 billion of senior notes
  • approximately $6 billion registered offering of senior notes and $4 billion tender offer to purchase outstanding notes
  • registered offering of approximately $4.5 billion of senior notes
• Imperial Dade in its issuance of $660 million of senior notes
• A consortium of private equity investors in the issuance of approximately $2.075 billion of senior notes to finance the acquisition of Inmarsat
• Ladder Capital in its:
  
  • issuance of $750 million of senior notes
  • issuance of $500 million of senior notes
• Owens & Minor in its:
  
  • issuance of $500 million of senior notes
  • issuance of $600 million of senior notes
• PetSmart in its:
  
  • issuance of $1.2 billion of senior first lien notes and $1.15 billion of senior notes
  • in the private offering by the 2020 Mandatory Exchangeable Trust of mandatory exchangeable trust securities
• Pike Corporation in its issuance of $500 million of senior notes
• Staples in connection with a comprehensive debt refinancing that included the issuance of approximately $2.4 billion of new senior secured notes and an exchange offer of approximately $950 million of its existing senior notes
• Townsquare Media in its issuance of $550 million of senior notes
• The underwriters in connection with Visa’s:
  
  • $4 billion senior notes offering
  • $3.25 billion senior notes offering
• Wyndham Destinations in its issuance of $500 million of senior notes

M&A Transactions

• AbbVie in its approximately $63 billion acquisition of Allergan
• Bristol Myers Squibb in its:
  
  • approximately $90 billion acquisition of Celgene
  • up to approximately $5.8 billion acquisition of Mirati
  • approximately $4.1 billion acquisition of Turning Point
• Lilly in its:
  
  • approximately $2.4 billion acquisition of DICE
  • approximately $1.4 billion acquisition of Point Biopharma
  • approximately $500 million acquisition of Akouos
• Owens & Minor in its approximately $1.6 billion acquisition of Apria
• BC Partners on the sale of a minority stake in PetSmart

Equity Transactions

• Chewy in its:
  
  • $1.2 billion initial public offering
  • various secondary registered offerings and block trades by selling stockholders
• Ladder Capital in its approximately $100 million follow-on offering and $100 million ATM program
• Pharvaris N.V. in its initial public offering and ATM program
• Perceptive Advisers in connection with its participation in a private placement in Lyra Therapeutics
• Torrid Holdings in its:
  • initial public offering at a $2.3 billion valuation
  • secondary registered offering of approximately $40 million
• Genius Sports in its underwritten public offering of approximately $150 million

Special Situations

• WeWork on its comprehensive restructuring of its capital structure
• Avaya in connection with its financial restructuring and emergence from bankruptcy